Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-04-08 16:38:25 ET · period of report 2026-04-07 · accession 0001464583-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-08 16:38 | 2026-04-07 | KNSA | Megna Michael R | CAO | M - OptEx | $1.00 | +3,932 | 35.7K | +12% | +$3,932 |
| D | 2026-04-08 16:38 | 2026-04-07 | KNSA | Megna Michael R | CAO | F - Tax | $48.94 | -1,666 | 34.0K | -5% | -$81.5K |
| D | 2026-04-08 16:38 | 2026-04-07 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -3,932 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-04-07 | M | A | 3,932 | $1.00 | 35,709 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Common | Class A Ordinary Share | 2026-04-07 | F | D | 1,666 | $48.94 | 34,043 | D | — | — | |
| 3 | Derivative | Restricted Share Unit | 2026-04-07 | M | D | 3,932 | $0.00 | 0 | D | — · — to — | 3,932 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. |